Back to companies
Neuphoria Therapeutics Inc.
NEUPUSNASDAQPharmaceuticals & HealthcareNeuphoria Therapeutics Inc.
Revenue
$1.2mn
YoY -92.5%
Operating income
-$16.5mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API